GGrantIndex
Sort

40,608 grants matching prostate cancer

Roles of SRC-3 in Development and Disease

$310,051
Jianming Xu · Baylor College Of Medicine · R01 · FY2011 · DK

Functional and inhibitory studies of human lipoxygenase

$310,049
Theodore R Holman · University Of California Santa Cruz · R01 · FY2008 · GM

LOCALIZATION OF SUSCEPTIBILITY LOCI IN PROSTATE CANCER

$310,046
Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2003 · CA

Novel roles of microRNA in androgen receptor signaling

$310,025
Allen C Gao · University Of California At Davis · R01 · FY2015 · CA

Skp2 in androgen-dependent proliferation of prostate cancer cells

$310,005
Liang Zhu · Albert Einstein College Of Medicine · R01 · FY2010 · CA

Skp2 in androgen-dependent proliferation of prostate cancer cells

$310,005
Liang Zhu · Albert Einstein College Of Medicine · R01 · FY2009 · CA

Gold Compounds for the Topical Treatment of Trichomoniasis

$310,000
Lars Eckmann · University Of California, San Diego · R21 · FY2015 · AI

Signal Termination by PHLPP, PH domain Leucine-rich repeat Protein Phosphatase

$310,000
Alexandra C. Newton · University Of California, San Diego · R01 · FY2012 · GM

A multiomic analysis of HER2/ERBB2 in African American men with prostate cancer

$309,978
Leanne Burnham · Morehouse School Of Medicine · U54 · FY2023 · MD

Conjoint Analysis: Overcoming Obstacles to Routine Formal Preference Assessment i

$309,965
Christopher Saigal · University Of California Los Angeles · R01 · FY2011 · CA

Mechanistic Studies on Prostate Cancer Prevention by Gugulipid

$309,964
Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA

The 26S Proteasome in Cancer Stem Cells

$309,964
Frank Pajonk · University Of California Los Angeles · R01 · FY2012 · CA

New Mice Models for Studies of Androgen Receptor in Prostate Cancer

$309,964
Chawnshang Chang · University Of Rochester · R01 · FY2011 · CA

Development of a Novel HCS Assay to Screen for Disruptors of AR-TIF2 Interactions

$309,964
Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA

Dynamics of Histone Acetylation in Cancer Cell Physiology

$309,964
Siavash Kurdistani · University Of California Los Angeles · R01 · FY2014 · CA

A novel strategy to identify prostate cancer biomarkers for patient management

$309,964
Jiaoti Huang · University Of California Los Angeles · R01 · FY2014 · CA

Antibody-interferon fusion proteins for treatment of B-cell malignancies

$309,964
Sherie L Morrison · University Of California Los Angeles · R01 · FY2014 · CA

Tyrosine Kinases and Prostate Cancer

$309,964
Hsing-Jien Kung · University Of California At Davis · R01 · FY2014 · CA

New Mice Models for Studies of Androgen Receptor in Prostate Cancer

$309,964
Chawnshang Chang · University Of Rochester · R01 · FY2012 · CA

NF-kB Signaling in Osteoclastogenesis and Osteolytic Bone Metastasis

$309,964
Cun-Yu Wang · University Of California Los Angeles · R01 · FY2012 · CA

The 26S Proteasome in Cancer Stem Cells

$309,964
Frank Pajonk · University Of California Los Angeles · R01 · FY2011 · CA

NF-kB Signaling in Osteoclastogenesis and Osteolytic Bone Metastasis

$309,964
Cun-Yu Wang · University Of California Los Angeles · R01 · FY2011 · CA

A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment

$309,964
Gang Zeng · University Of California Los Angeles · R01 · FY2014 · CA

Conjoint Analysis: Overcoming Obstacles to Routine Formal Preference Assessment i

$309,962
Christopher Saigal · University Of California Los Angeles · R01 · FY2012 · CA

The Role of Mechanotransduction in Progression of Tumor-induced Bone Disease

$309,945
Scott A Guelcher · Vanderbilt University · R01 · FY2015 · CA